Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
37.06
+0.36 (0.98%)
Jan 17, 2025, 4:00 PM EST - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.11 billion as of January 21, 2025. Its market cap has increased by 58.83% in one year.
Market Cap
2.11B
Enterprise Value
1.37B
1-Year Change
58.83%
Ranking
Category
Stock Price
$37.06
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.11B, an increase of 160.71%. That is a compound annual growth rate of 88.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 2.11B | -18.19% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |